Novel multi-drugs incorporating hybrid-structured nanofibers enhance alkylating agent activity in malignant gliomas
2019
Background:Malignant gliomas (MGs) are highly chemotherapy-resistant. Temozolomide (TMZ) and carmustine (BiCNU) are alkylating agents clinically used for treating MGs. However, their effectiveness ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
42
References
3
Citations
NaN
KQI